Neuromodulation Systems Market (2025-2032)
The Neuromodulation Systems Market is projected to reach $10.29 billion by 2032, at a CAGR of 8.2% from 2025 to 2032.
- Published
- Jan 2025
- Pages
- 190
- Format
- PDF + Excel
- Report ID
- MRHC - 104792
- Base year
- 2024
- 2032 · FORECAST
- $10.29B
- 2032
- $10.29B
- CAGR 2025–2032
- 8.2%
2024 baseline · 2025–2032 forecast at 8.2% CAGR · hover a bar for the value
Key highlights
The Neuromodulation Systems Market is projected to reach $10.29 billion by 2032, at a CAGR of 8.2% from 2025 to 2032.
The internal neuromodulation segment is expected to account for the largest share
North America’s major market share is attributed to the high prevalence of neurological disorders, availability of advanced treatment options, well-established healthcare system, significant investments in healthcare, and the growth in the geriatric population.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 10.29 billion |
| CAGR (2025–2032) | 8.2% |
| Format | PDF, Excel & Cloud Portal · 190 pages |
| Segments Covered | By Type: Post-surgical Pain, Arachnoiditis, Other SCS Applications, Parkinson's Disease, Essential Tremor, Depression, Other DBS Applications, Urine incontinence, Fecal incontinence, Epilepsy, Other VNS Applications, Gastroparesis, Obesity, Transcranial Magnetic Stimulation (TMS), by Application Psychiatry · By Application: Parkinson's Disease, Tremor, Depression, Epilepsy, Gastroparesis, Obesity, Psychiatry, Neurology, Pediatrics |
| Countries Covered | Europe (RoE), Asia-Pacific (RoAPAC), Latin America (RoLATAM) |
| Key Companies | Nevro Corp. (U.S.), Medtronic plc, Abbott Laboratories (U.S.), NeuroSigma, Inc. (U.S.), Neuronetics, Inc. (U.S.), NeuroPace, Inc. (U.S.), Bioventus Inc. (U.S.), MicroTransponder, Inc. (U.S.), Soterix Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Synapse Biomedical Inc. (U.S.), Aleva Neurotherapeutics SA |
Report overview
Segments covered: type, application. Regions: Europe, Asia-Pacific, Latin America.
Neuromodulation devices are medical tools used to modify the activity of the nervous system by altering the electrical or chemical signals within the brain and spinal cord. These devices are used to treat a wide range of conditions, such as chronic pain, movement disorders, and depression, by changing how nerve cells communicate and transmit signals.
Neuromodulation devices can be implantable, such as deep brain stimulators or spinal cord stimulators, or non-invasive, such as transcutaneous electrical nerve stimulation (TENS) units. Neuromodulation aims to provide targeted and effective relief to specific areas of the nervous system in a safe and controlled manner. The specific type of neuromodulation device used depends on the target area and the condition being treated.
For example, deep brain stimulation (DBS) devices are used to treat movement disorders, such as Parkinson's disease, by delivering electrical stimulation to specific regions of the brain. On the other hand, spinal cord stimulation (SCS) devices are used to relieve chronic pain by delivering electrical stimulation to the spinal cord.
The high prevalence of neurological disorders and nerve injuries, advancements in neuromodulation & neurostimulation technologies, and expanding applications of neuromodulator systems are the factors driving the growth of this market. Furthermore, emerging economies and the increasing demand for non-invasive devices are expected to offer significant growth opportunities for market expansion. However, the shortage of skilled healthcare professionals and regulatory barriers and recall of neuromodulator systems pose a major challenge to the growth of the neuromodulation systems market.
Report infographic
Market dynamics
1 factors across 1 forceEmerging Economies in Asia-Pacific and Latin America Offer Significant Opportunities for the Market’s Growth
Emerging economies, such as India, China, and Brazil, have a large and growing population of individuals with neurological disorders and nerve injuries. According to Indian Stroke Association (ISA), the prevalence of stroke is rising in India, with nearly 1.8 million new cases reported annually. Stroke, headache disorders, and epilepsy are the leading contributors to neurological disorders burden in India.
These economies are also experiencing a significant increase in the aging population, which is a risk factor for many neurological conditions. Thus, there is a growing focus on developing and introducing neuromodulation devices, developing local manufacturing capabilities, introducing new and innovative devices, and establishing distribution and service networks in emerging economies to meet the growing demand for effective treatments for these conditions. Efforts are also underway to increase patient awareness and access to these devices in emerging economies by expanding public and private healthcare systems and educating and training healthcare professionals.
Table of contents
9 chapters · 107 sections · 190 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Type | Internal neuromodulation | — |
By Type
- The internal neuromodulation segment is expected to account for the largest share
- The factors contributing to the large market share of this segment are the growing number of people with various conditions such as depression, chronic pain, and heart-related diseases.
- Internal neuromodulation devices are more effective than external devices as they can directly stimulate the target neural circuits, leading to better outcomes for patients.
- These devices are convenient for long-term use, can be customized according to patient needs, and increases patient compliance.
- The internal stimulation segment is further subsegmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation.
- The spinal cord stimulation segment is expected to account for the largest share of the market.
Geographic analysis
North America
Largest shareNorth America’s major market share is attributed to the high prevalence of neurological disorders, availability of advanced treatment options, well-established healthcare system, significant investments in healthcare, and the growth in the geriatric population. The region has a high prevalence of neurological disorders, such as chronic pain, depression, Parkinson's disease, and epilepsy, driving demand for effective treatments, including neuromodulation devices. Furthermore, North America's well-developed healthcare system enables access to advanced treatment options, including neuromodulation devices. This has helped to increase patient awareness and access to these devices. Major players operating in the field of neuromodulation systems are from the U.S. Additionally, North America’s well-established healthcare system enables the development, introduction, and widespread adoption of advanced medical technologies, including neuromodulation devices. Also, the growth in the aging population results in the high prevalence of neurological conditions, which drives demand for effective treatments, including neuromodulation systems. North America Expected to be the Largest Regional Market in 2025
Competitive landscape
- Nevro Corp. (U.S.)
- Medtronic plc · Ireland
- Abbott Laboratories (U.S.)
- NeuroSigma, Inc. (U.S.)
- Neuronetics, Inc. (U.S.)
- NeuroPace, Inc. (U.S.)
- Bioventus Inc. (U.S.)
- MicroTransponder, Inc. (U.S.)
- Soterix Medical, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Synapse Biomedical Inc. (U.S.)
- Aleva Neurotherapeutics SA · Switzerland
Frequently asked questions
This study offers a detailed assessment of the neuromodulation systems market, including the market sizes & forecasts for various segmentation such as type and geography. This report also involves the value analysis of various segments and subsegments of neuromodulation systems at the regional and country levels.
Cite this report
Meticulous Research. (2025). Neuromodulation Systems Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104792). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/neuromodulation-systems-market-5476